Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 5, 2014, Pages E456-E461

  Beggs, Luke A ^a   Yarrow, Joshua F ^a   Conover, Christine F ^a   Meuleman, John R ^a   Beck, Darren T ^b   Morrow, Matthew ^a   Zou, Baiming ^a   Shuster, Jonathan J ^a   Borst, Stephen E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Androgen; Finasteride; Hematocrit; Hepcidin; Hypogonadal; Testosterone

Indexed keywords

ANDROSTANOLONE; FERRITIN; FINASTERIDE; HEMOGLOBIN; HEPCIDIN; IRON; PLACEBO; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE ENANTATE; TRANSFERRIN; ANDROGEN; DRUG DERIVATIVE;

AGED; ARTICLE; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FACTORIAL DESIGN; FERRITIN BLOOD LEVEL; HEMATOCRIT; HOMEOSTASIS; HUMAN; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PROSTATE; TRANSFERRIN BLOOD LEVEL; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INTERACTION; HYPOGONADAL; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ANDROGEN; FINASTERIDE; HEMATOCRIT; HEPCIDIN; HYPOGONADAL; TESTOSTERONE;

AGED; AGED, 80 AND OVER; DIHYDROTESTOSTERONE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ERYTHROCYTE COUNT; ERYTHROCYTES; FERRITINS; FINASTERIDE; HUMANS; IRON; MALE; MIDDLE AGED; PLACEBOS; TESTOSTERONE; TRANSFERRIN;

EID: 84907764334     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00184.2014     Document Type: Article

References (38)

1. Alexanian R, Vaughn WK, Ruchelman MW. Erythropoietin excretion in man following androgens. J Lab Clin Med 70: 777-785, 1967.
2. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89: 503-510, 2004.
3. Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S. Testosterone suppresses hepcidin in men: a potential mechanism for testosteroneinduced erythrocytosis. J Clin Endocrinol Metab 95: 4743-4747, 2010.
4. Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V, Bhasin S. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci 69: 725-735, 2013.
5. Beggs LA, Borst SE, Yarrow JF. Testosterone regulates hepcidin. J Clin Invest 2013. e-letter: http://www.jci.org/eletters/view/67225#sec1.
6. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536-2559, 2010.
7. Bhasin S, Travison TG, Storer TW, Lakshman K, Kaushik M, Mazer NA, Ngyuen AH, Davda MN, Jara H, Aakil A, Anderson S, Knapp PE, Hanka S, Mohammed N, Daou P, Miciek R, Ulloor J, Zhang A, Brooks B, Orwoll K, Hede-Brierley L, Eder R, Elmi A, Bhasin G, Collins L, Singh R, Basaria S. Effect of testosterone supplementation with and without a dual 5alpha-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA 307: 931-939, 2012.
8. Borst SE, Conover CF, Carter CS, Gregory CM, Marzetti E, Leeuwenburgh C, Vandenborne K, Wronski TJ. Anabolic effects of testosterone are preserved during inhibition of 5-reductase. Am J Physiol Endocrinol Metab 293: E507-E514, 2007.
9. Borst SE, Lee JH, Conover CF. Inhibition of 5-reductase blocks prostate effects of testosterone without blocking anabolic effects. Am J Physiol Endocrinol Metab 288: E222-E227, 2005.
10. Borst SE, Yarrow JF, Conover CF, Nseyo U, Meuleman JR, Lipinska JA, Braith RW, Beck DT, Martin JS, Morrow M, Roessner S, Beggs LA, McCoy SC, Cannady DF IInd, Shuster JJ. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab 306: E433-E442, 2014.
11. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebocontrolled trials. J Gerontol A Biol Sci Med Sci 60: 1451-1457, 2005.
12. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93: 914-919, 2008.
13. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95: 2560-2575, 2010.
14. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 166: 1380-1388, 2006.
15. Fried W, Gurney CW. The erythropoietic-stimulating effects of androgens. Ann NY Acad Sci 149: 356-365, 1968.
16. Granata OM, Cocciadifero L, Campisi I, Miceli V, Montalto G, Polito LM, Agostara B, Carruba G. Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells. J Steroid Biochem Mol Biol 113: 290-295, 2009.
17. Guo W, Bachman E, Li M, Roy CN, Blusztajn J, Wong S, Chan SY, Serra C, Jasuja R, Travison TG, Muckenthaler MU, Nemeth E, Bhasin S. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 12: 280-291, 2013.
18. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 34: 513-554, 2004.
19. Hero M, Wickman S, Hanhijarvi R, Siimes MA, Dunkel L. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. J Pediatr 146: 245-252, 2005.
20. Hou Y, Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 511: 398-403, 2012.
21. Ikeda Y, Tajima S, Izawa-Ishizawa Y, Kihira Y, Ishizawa K, Tomita S, Tsuchiya K, Tamaki T. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One 7: e40465, 2012.
22. Jin Y, Penning TM. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract Res Clin Endocrinol Metab 15: 79-94, 2001.
23. Langlois VS, Zhang D, Cooke GM, Trudeau VL. Evolution of steroid 5alpha-reductases and comparison of their function with 5beta-reductase. Gen Comp Endocrinol 166: 489-497, 2010.
24. Latour C, Kautz L, Besson-Fournier C, Island ML, Canonne-Hergaux F, Loreal O, Ganz T, Coppin H, Roth MP. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology 59: 683-694, 2014.
25. Maggio M, Snyder PJ, Ceda GP, Milaneschi Y, Luci M, Cattabiani C, Masoni S, Vignali A, Volpi R, Lauretani F, Peachey H, Valenti G, Cappola AR, Longo D, Ferrucci L. Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men. Andrology 1: 24-28, 2013.
26. McCoy SC, Yarrow JF, Conover CF, Borsa PA, Tillman MD, Conrad BP, Pingel JE, Wronski TJ, Johnson SE, Kristinsson HG, Ye F, Borst SE. 17-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement. Bone 51: 667-673, 2012.
27. Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood 123: 168-176, 2014.
28. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
29. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90: 1502-1510, 2005.
30. Rochira V, Zirilli L, Madeo B, Maffei L, Carani C. Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men. J Steroid Biochem Mol Biol 113: 189-194, 2009.
31. Schooley JC. Inhibition of erythropoietic stimulation by testosterone in polycythemic mice receiving anti-erythropoietin. Proc Soc Exp Biol Med 122: 402-403, 1966.
32. Shahani S, Braga-Basaria M, Maggio M, Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest 32: 704-716, 2009.
33. Shahidi NT. Androgens and erythropoiesis. N Engl J Med 289: 72-80, 1973.
34. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672, 1999.
35. Vigen R, O’Donnell CI, Baron AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310: 1829-1836, 2013.
36. Yarrow JF, Conover CF, McCoy SC, Lipinska JA, Santillana CA, Hance JM, Cannady DF, VanPelt TD, Sanchez J, Conrad BP, Pingel JE, Wronski TJ, Borst SE. 17-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate. Am J Physiol Endocrinol Metab 300: E650-E660, 2011.
37. Yarrow JF, McCoy SC, Borst SE. Intracrine and myotrophic roles of 5alpha-reductase and androgens: a review. Med Sci Sports Exerc 44: 818-826, 2012.
38. Zhao N, Zhang AS, Enns CA. Iron regulation by hepcidin. J Clin Invest 123: 2337-2343, 2013